[1] Insel TR. Rethinking schizophrenia[J]. Nature, 2010, 468: 187-193. [2] Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia[J]. Arch Gen Psychiat, 1987, 44: 660-669. [3] Brown AS. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism[J]. Dev Neurobiol, 2012, 72: 1272-1276. [4] Miller BJ, Goldsmith DR. Towards an immunophenotype of schizophrenia: progress, potential mechanisms, and future directions[J]. Neuropsychopharmacology, 2017, 42: 299-317. [5] Feigenson KA, Kusnecov AW, Silverstein SM. Inflammation and the two-hit hypothesis of schizophrenia[J]. Neurosci Biobehav Rev, 2014, 38: 72-93. [6] Giovanoli S, Engler H, Engler A, et al. Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia[J]. Transl Psychiatry, 2016, 6: e772. doi: 10.1038/tp.2016.38. [7] Giovanoli S, Engler H, Engler A, et al. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice[J]. Science, 2013, 339: 1095-1099. [8] Khan A, Powell SB. Sensorimotor gating deficits in “two-hit” models of schizophrenia risk factors[J]. Schizophr Res, 2018, 198: 68-83. [9] Goh JY, O'Sullivan SE, Shortall SE, et al. Gestational poly(I:C) attenuates, not exacerbates, the behavioral, cytokine and mtor changes caused by isolation rearing in a rat ‘dual-hit' model for neurodevelopmental disorders[J]. Brain Behav Immun, 2020, 89: 100-117. [10] Yee N, Ribic A, de Roo CC, et al. Differential effects of maternal immune activation and juvenile stress on anxiety-like behaviour and physiology in adult rats: No evidence for the “double-hit hypothesis”[J]. Behav Brain Res, 2011, 224: 180-188. [11] Clark SM, Notarangelo FM, Li X, et al. Maternal immune activation in rats blunts brain cytokine and kynurenine pathway responses to a second immune challenge in early adulthood[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2019, 89: 286-294. [12] Estes ML, McAllister AK. Maternal immune activation: implications for neuropsychiatric disorders[J]. Science, 2016, 353: 772-777. |